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ABSTRACT
Background: Health concerns have been raised about rice consump-
tion, which may signiﬁcantly contribute to arsenic exposure. How-
ever, little is known regarding whether habitual rice consumption is
associated with cardiovascular disease (CVD) risk.
Objective: We examined prospectively the association of white rice
and brown rice consumption with CVD risk.
Design: We followed a total of 207,556 women and men [73,228
women from the Nurses’ Health Study (1984–2010), 92,158 women
from the Nurses’ Health Study II (1991–2011), and 42,170 men
from the Health Professionals Follow-Up Study (1986–2010)]
who were free of CVD and cancer at baseline. Validated semiquan-
titative food-frequency questionnaires were used to assess consump-
tion of white rice, brown rice, and other food items. Fatal and
nonfatal CVD (coronary artery disease and stroke) was conﬁrmed
by medical records or self-reports.
Results: During 4,393,130 person-years of follow-up, 12,391 cases
of CVD were identiﬁed. After adjustment for major CVD risk factors,
including demographics, lifestyle, and other dietary intakes, rice con-
sumption was not associated with CVD risk. The multivariable-
adjuted HR of developing CVD comparing $5 servings/wk with
,1 serving/wk was 0.98 (95% CI: 0.84, 1.14) for white rice, 1.01
(0.79, 1.28) for brown rice, and 0.99 (0.90, 1.08) for total rice. To
minimize the potential impact of racial difference in rice consump-
tion, we restricted the analyses to whites only and obtained similar
results: the HRs of CVD for $5 servings/wk compared with
,1 serving/wk were 1.04 (95% CI: 0.88, 1.22) for white rice
and 1.01 (0.78, 1.31) for brown rice.
Conclusions: Greater habitual consumption of white rice or brown
rice is not associated with CVD risk. These ﬁndings suggest that rice
consumption may not pose a signiﬁcant CVD risk among the U.S.
population when consumed at current amounts. More prospective
studies are needed to explore these associations in other popula-
tions. Am J Clin Nutr 2015;101:164–72.
Keywords cardiovascular disease, coronary artery disease,
longitudinal study, rice, stroke
INTRODUCTION
Rice plays an important role as a staple food in more than half
of the global populations, especially in the Asian population. Per
capitariceconsumptionisalsoincreasingintheUnitedStates(1).
Meanwhile, rice consumption has been identiﬁed as an important
route of arsenic exposure among populations not living in arsenic-
endemic regions (2–4), as well as populations in arsenic-endemic
regions, such as Bangladesh, Taiwan, and India, where ground-
water is heavily contaminated by arsenic (5, 6). Recently, a health
concern regarding rice consumption has been raised in the United
States because rice grains, especially brown rice and its products,
contain a high concentration of arsenic, according to a recent U.S.
survey, and because in the National Health and Nutrition Exami-
nation Survey, urinary arsenic concentration was substantially
higher among individuals who consumed rice than among those
did not (7). Responding to this concern, the U.S. Food and Drug
Administration reported that arsenic concentration in rice grains is
too low to cause acute health effects of arsenic exposure, but the
chronic effects of arsenic exposure from rice consumption have
not been evaluated (8). Data regarding associations between rice
consumption and risk of cardiovascular disease (CVD)
5 are sparse
and mixed. In a Japanese population who consumed white rice as
a staple food, greater rice consumption was associated with lower
mortality from CVD, especially coronary artery disease (CAD), in
men, whereas in women, the association was not evident (9). In
another Japanese study, there was a null association of risk of CVD,
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164 Am J Clin Nutr 2015;101:164–72. Printed in USA.CAD, and stroke with rice consumption, although rice was the
major source of arsenic intake in this Japanese population (10, 11).
In contrast, among Chinese adults, greater carbohydrate intake
mostly from white rice was associated with higher CAD in-
cidence (12).
To our knowledge, no prospective study has been conducted to
evaluate whether low rice consumption typical of Western
populations is associated with CVD risk and whether white rice
and brown rice intakes are differentially associated with CVD
risk because of various contents of nutrients and arsenic, as well
as different glycemic characteristics in these 2 types of rice. We
therefore examined the prospective associations of white rice and
brown rice with CVD risk among U.S. men and women par-
ticipating in the Nurses’ Health Study (NHS), the Nurses’ Health
Study II (NHSII), and the Health Professionals Follow-Up Study
(HPFS).
SUBJECTS AND METHODS
Study population
The NHS was established in 1976 with a total enrollment of
121,701 female registered nurses (13). The NHSII, established in
1989, enrolled 116,430 younger nurses (14). The HPFS, estab-
lished in 1986, consisted of 51,529 male health professionals
(13). At baseline, to examine the associations between con-
sumptionofwhite riceorbrown riceand theprimaryincidence of
CVD, we excluded participants who reported a diagnosis of CVD
(n = 3072 in 1984 for NHS, 1012 in 1991 for NHSII, and 4116
in 1986 for HPFS) and those who had missing data regarding
white rice or brown rice consumption (n = 1014 for NHS, 812
for NHSII, and 1821 for HPFS). To minimize the impact of
reverse causation caused by possible dietary changes after a di-
agnosis with chronic diseases, we excluded participants who
reported a diagnosis of cancer (n = 4409 in 1984 for NHS, 1335
in 1991 for NHSII, and 2063 in 1986 for HPFS). We also ex-
cluded participants who had unusual amount of total en-
ergy intake (,500 or .3500 kcal/d for women and ,800 or
.4200 kcal/d for men), which meant unreliable response to
food-frequency questionnaires (FFQs) (n = 2288 for NHSII and
1359 for HPFS). After these exclusions, 73,228 participants in
NHS (1984–2010), 92,158 participants in NHSII (1991–2011),
and 42,170 participants in HPFS (1986–2010) were included in
the current analysis. The study protocols were approved by the
institutional review boards of the Brigham and Women’s Hos-
pital and the Harvard School of Public Health. Completion and
return of study questionnaires implied informed consent of the
participants.
Assessments of diet and other characteristics
In 1984, 1986, and every 4 y thereafter, semiquantitative FFQs
with 118–166 items were mailed to the NHS participants to
assess and update information on their usual intake of foods and
beverages in the past year. The FFQs have been sent every 4 y to
the NHSII participants since 1991 and to the HPFS participants
since 1986. We asked the participants how often, on average,
they consumed white rice and brown rice with a standard portion
size of 1 cup (158 g for cooked white rice and 195 g for cooked
brown rice). There were 9 possible responses, ranging from
“never or less than once per month” to “6 or more times per
day.” We used the same method to assess consumption of other
foods. Nutrient intakes were estimated by multiplying the fre-
quency of each food intake by the nutrient values for each food
item with the speciﬁed serving size and summing the nutrient
intake from all food items (15, 16). We derived an alternative
Healthy Eating Index (aHEI) score as an indicator of adherence
to healthy eating behavior by summarizing consumption of 11
foods and nutrients: vegetables, fruits, whole grains, sugar-
sweetened beverages and fruit juice, nuts and legumes, red and
processed meat, trans fat, long-chain n–3 fat, polyunsaturated
fat, sodium, and alcohol (17). In the current study, we modiﬁed
the aHEI score by excluding brown rice from the whole-grain
consumption calculation. The validation study of the FFQ was
previously evaluated by using multiple-day diet records as the
reference method (see Supplemental Methods) (15, 16, 18, 19).
The performance of our FFQ is similar to that of other FFQs
(20–23). Based on our FFQ, consumption of white rice and
brown rice contributed 15% and 7% of total arsenic intake on
average, respectively (24).
In the follow-up questionnaires, we inquired about multiple
demographic and lifestyle risk factors of CVD (see Supplemental
Methods). In addition, we linked participants’ residential zip
code with arsenic concentration in groundwater collected from
county-speciﬁc data described in detail at the U.S. Geological
Survey website (see Supplemental Methods) (25). We catego-
rized the groundwater arsenic concentration into 3 groups based
on the number of participants in each category and the U.S.
Environmental Protection Agency regulation of arsenic con-
centration in drinking water: ,3.0, 3.0–9.9, and $10.0 mg/L
(ppb) of groundwater arsenic concentration (26). Of note, we did
not collect data on individual-level overall arsenic exposure such
as urinary arsenic concentrations.
Assessment of cardiovascular disease and death
The CVD outcomes included nonfatal myocardial infarction
(MI), fatal CAD, and stroke (nonfatal or fatal). Brieﬂy, the in-
cidence of nonfatal MI and stroke was ascertained from the
biennial follow-up questionnaires and conﬁrmed by reviewing
medical records with the World Health Organization criteria for
MI (27) or the National Survey of Stroke criteria for stroke (see
Supplemental Methods) (28). Deaths were identiﬁed by reports
from next of kin or postal authorities or by searching the National
Death Index. In a validation study among the NHS participants,
98% of deaths reported by kin or postal authorities were also
identiﬁed by searching the National Death Index (29). In each
cohort, the cause of death was conﬁrmed by reviewing medical
records or reliable sources such as autopsy records for more than
65% of deaths. Fatal cases of CAD and stroke were identiﬁed if
CAD or stroke was listed as the cause of death in multiple
sources, including autopsy reports, hospital records, and death
certiﬁcates.
Statistical analysis
For each participant, we calculated person-years from the date
when the baseline questionnaire was returned to the date when
participants were diagnosed with CVD, the date of death, or the
end of follow-up (2010 for NHS and HPFS or 2011 for NHSII),
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minimize within-person variation, we calculated and used the
cumulative average of intakes from all FFQs in our analyses (30).
Tominimizetheimpactofpotentialoutliersandfacilitatepooling
the results from the 3 cohorts, we used the same cutoff points of
rice consumption to categorize participants based on the con-
siderations of consumption categories used in FFQs, distribu-
tion of rice consumption, and the hypothesis of interest that
.2 servings/wk of rice consumption is associated with CVD
risk. The categories used were: ,1 serving/wk, 1 serving/wk, 2–4
servings/wk, and $5 servings/wk.
The HRs and 95%CIs ofincident CVDwere estimatedfor rice
consumption by using time-dependent Cox proportional hazards
regression after pooling data from 3 cohorts (31). The analysis
was stratiﬁed jointly by age, cohorts, and calendar year and
adjusted for various potential confounding factors, including
baseline variables of sex, ethnicity, family history of MI, prev-
alent hypertension, hypercholesterolemia, or diabetes, and time-
varying covariates of BMI, physical activity, cigarette smoking,
alcohol intake, multivitamin use, menopausal status and post-
menopausal hormone use (for women), oral contraceptive use
(for NHSII only), current aspirin use, total energy intake, and the
modiﬁed aHEI score. A test for linear trend was performed by
modeling the median values for rice consumption categories as
a continuous variable.
Because white rice consumption was largely different between
Asians and other ethnicities, we also evaluated the associations
among whites (n = 184,800) and Asians (n = 2660) separately.
We examined potential interactions of consumption of white rice
or brown rice with BMI, physical activity, smoking status, and
the modiﬁed aHEI score by using a Wald test to evaluate the
signiﬁcance of the interaction terms between these variables and
rice consumption. In addition, as an exploratory analysis, we
analyzed the data stratiﬁed by groundwater arsenic concentra-
tion in the participant’s county of residence instead of individual
concentrations of overall arsenic exposure. To evaluate the ro-
bustness of our ﬁndings, we conducted 3 sensitivity analyses
adjusting for individual dietary factors (including alcohol intake,
polyunsaturated-to-saturated fat ratio, and intakes of trans fat,
red meat, ﬁsh, fruits, vegetables, nuts, whole grains, coffee, and
sugar-sweetened beverages) instead of the modiﬁed aHEI score,
excluding participants who had prevalent hypertension at base-
line or updating dietary information every 8 y instead of every
4 y (see Supplemental Methods). Statistical analyses were per-
formed by using SAS 9.3 (SAS Institute). All P values were
2-sided, with statistical signiﬁcance deﬁned as P , 0.05.
RESULTS
During 4,393,130 person-years offollow-up, 7719participants
developed CAD and 4672 participants developed stroke (NHS:
3060 CAD cases and 2703 stroke cases during 1,731,139 person-
years; NHSII: 534 CAD cases and 494 stroke cases during
1,812,190 person-years; and HPFS: 4125 CAD cases and 1475
stroke cases during 849,801 person-years). At baseline, con-
sumption of white rice and brown rice was inversely correlated
with smoking, aspirin use, and oral contraceptive use (Table 1).
Asians were more likely to consume white rice, but not brown
rice, than other ethnicities. Greater white rice consumption was
associated with lower consumption of whole grains and lower
probability of having a family history of MI. Brown rice con-
sumption was positively associated with physical activity, con-
sumption of whole grains, and history of postmenopausal
hormone use, as well as inversely correlated with BMI.
In the age-adjusted model, consumption of white rice, brown
rice, and total rice was inversely associated with CVD risk
(Table 2). After adjustment for demographic and lifestyle fac-
tors as well as modiﬁed aHEI score, these inverse associations
were largely attenuated and no longer signiﬁcant. Comparing
extreme categories of rice consumption, the multivariable-
adjusted HRs of CVD were 0.98 (95% CI: 0.84, 1.14) for white
rice, 1.01 (0.79, 1.28) for brown rice, and 0.99 (0.90, 1.08) for
total rice (P-trend = 0.69, 0.32, and 0.86, respectively). We did
not detect statistically signiﬁcant interactions of white rice and
brown rice with BMI, physical activity, smoking status, and
modiﬁed aHEI score in relation to CVD risk (Supplemental
Figure 1).
We did not observe positive associations of white rice, brown
rice, and total rice with CAD risk either (Table 2). With ad-
justment for demographic, lifestyle, and dietary factors, com-
paring extreme categories, the HRs of CAD were 0.84 (95% CI:
0.69, 1.02) for white rice, 0.80 (0.57, 1.12) for brown rice, and
0.97 (0.86, 1.08) for total rice (P-trend = 0.87, 0.95, and 0.81,
respectively). In terms of stroke risk, $5 servings/wk of white
rice or brown rice was associated with a nonsigniﬁcant higher
risk compared with ,1 serving/wk. Such a positive trend was
not found for total rice. The multivariable-adjusted HRs of
stroke were 1.25 (95% CI: 0.99, 1.57; P = 0.06) for white rice,
1.39 (0.99, 1.96; P = 0.06) for brown rice, and 1.04 (0.89, 1.21;
P = 0.64) for total rice (P-trend = 0.69, 0.12, and 0.55,
respectively).
In a stratiﬁed analysis, the associations of white rice, brown
rice, and total rice with CVD remained null among whites and
Asians, respectively (see Supplemental Table 1). Comparing
extreme categories, the multivariable-adjusted HRs of CVD for
white rice were 1.04 (95% CI: 0.88, 1.22) among whites and
0.64 (0.30, 1.35) among Asians. The corresponding HRs were
1.01 (0.78, 1.31) and 0.53 (0.19, 1.45) for brown rice and 0.99
(0.90, 1.09) and 0.61 (0.24, 1.55) for total rice among whites and
Asians, respectively.
To explore the potential interaction between rice consumption
and background arsenic exposure in relation to CVD risk, we ﬁrst
examinedtheassociationofgroundwaterarsenicconcentrationin
the participant’s county of residence with CVD risk and found
null associations: compared with ,3.0 mg/L (ppb) of ground-
water arsenic concentration, the HRs of CVD risk were 0.95
(95% CI: 0.90, 1.01) for 3.0–9.9 mg/L (ppb) and 1.01 (0.94,
1.08) for $10 mg/L (ppb) (see Supplemental Table 2). The
associations of rice consumption with CVD risk, however, ap-
peared to be somewhat modiﬁed by groundwater arsenic con-
centration (see Supplemental Table 3)( P-interaction = 0.05 for
white rice, 0.95 for brown rice, and 0.14 for total rice). Among
participants living in low arsenic areas [,3.0 mg/L (ppb) of
groundwater arsenic concentration], white rice consumption was
positively associated with CVD risk, whereas among those who
lived in modest or high arsenic areas [3.0–9.9 and $10.0 mg/L
(ppb)], no association was found. However, the HR for each
consumption amount was not signiﬁcant probably because of
limited statistical power in the stratiﬁed analyses. Regarding
risk of CAD or stroke, interactions of total rice consumption
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Baseline characteristics of 73,228 women in the NHS (1984), 92,158 women in the NHSII (1991), and 42,170 men in the HPFS (1986) according to intake of
white rice and brown rice
1
White rice intake, servings/wk Brown rice intake, servings/wk
,1 1 2–4 $5 ,1 1 2–4 $5
NHS
n 48,473 18,852 5246 657 67,158 4552 1313 205
Age, y 50.6 6 7.2 49.3 6 7.1 49.3 6 7.1 50.2 6 6.9 50.1 6 7.2 50.3 6 7.1 50.9 6 7.2 51.6 6 6.6
BMI, kg/m
2 25.0 6 4.7 24.9 6 4.7 24.8 6 4.8 24.4 6 4.7 25.0 6 4.7 24.5 6 4.4 24.2 6 4.3 23.8 6 3.9
Physical activity, MET-h/wk 13.9 6 20.8 14.4 6 21.4 15.1 6 21.3 15.7 6 26.4 13.6 6 20.4 19.2 6 25.7 21.8 6 27.9 23.2 6 32.2
Alcohol intake, g/d 6.6 6 11.1 7.5 6 11.3 8.1 6 11.7 4.0 6 8.2 6.8 6 11.2 7.7 6 11.2 6.6 6 10.3 5.1 6 8.5
Current smoker, % 24.6 23.9 21.3 16.3 24.6 20.0 15.8 11.2
Ethnicity, %
White 98.8 98.1 93.6 50.7 97.8 98.0 96.5 90.7
Asian 0.2 0.2 1.7 42.0 0.7 0.4 1.1 2.9
African American 0.3 0.6 1.5 1.8 0.5 0.7 0.7 2.4
Hispanic/other 0.7 1.1 3.1 5.5 1.0 0.9 1.8 3.9
Family history of MI, % 39.1 38.6 37.6 30.6 38.9 39.0 35.7 37.1
Multivitamin use, % 37.3 36.0 37.4 37.3 36.0 46.0 52.5 48.8
Past or current PMH use, % 23.2 19.0 19.9 20.4 21.6 23.2 26.4 28.3
Hypertension, % 21.3 20.6 19.7 22.1 21.0 20.8 20.0 18.0
Hypercholesterolemia, % 8.0 7.6 8.5 9.0 7.8 9.1 11.6 8.8
Diabetes, % 2.9 2.6 2.8 4.6 2.9 2.6 2.9 2.9
Current aspirin use, % 66.3 68.7 67.4 55.9 67.3 64.7 58.5 50.2
Total energy intake, kcal/d 1668 6 514 1854 6 520 2025 6 538 1986 6 601 1733 6 528 1837 6 530 1949 6 544 2001 6 601
Glycemic load 98.6 6 20.4 99.2 6 17.6 102.0 6 17.8 113.7 6 21.2 98.8 6 19.6 101.1 6 18.6 106.9 6 19.6 119.8 6 24.2
White rice intake, servings/d — — — — 0.11 6 0.15 0.10 6 0.11 0.11 6 0.17 0.11 6 0.25
Brown rice intake, servings/d 0.03 6 0.10 0.03 6 0.07 0.03 6 0.09 0.04 6 0.15 ————
Whole-grain intake,
2 g/d 13.1 6 12.7 12.2 6 11.8 12.2 6 12.5 9.3 6 10.9 12.4 6 12.1 15.6 6 13.6 19.6 6 16.0 25.1 6 24.9
Modiﬁed aHEI score 45.6 6 10.6 45.8 6 9.6 47.1 6 9.7 49.6 6 10.1 45.2 6 10.0 51.6 6 10.2 55.3 6 10.2 60.0 6 10.8
NHSII
n 51,041 27,100 12,002 2015 75,473 11,711 4327 647
Age, y 35.9 6 4.7 36.3 6 4.6 36.4 6 4.6 36.3 6 4.6 36.1 6 4.7 36.0 6 4.6 36.3 6 4.5 36.6 6 4.5
BMI, kg/m
2 24.6 6 5.4 24.6 6 5.3 24.7 6 5.3 24.1 6 5.0 24.7 6 5.4 24.1 6 5.0 24.0 6 4.9 24.1 6 5.1
Physical activity, MET-h/wk 20.7 6 27.6 20.5 6 25.6 22.0 6 28.3 21.2 6 31.2 19.4 6 25.6 26.0 6 32.4 28.9 6 31.4 38.4 6 46.0
Alcohol intake, g/d 2.9 6 6.0 3.3 6 6.1 3.5 6 6.3 2.3 6 6.0 3.0 6 6.0 3.7 6 6.6 3.8 6 6.2 3.1 6 6.0
Current smoker, % 12.7 12.0 11.1 8.6 12.6 10.7 10.2 9.3
Ethnicity, %
White 97.5 96.6 92.1 54.2 95.4 97.1 96.1 88.7
Asian 0.4 0.8 2.5 37.3 1.7 0.8 0.9 4.3
African American 0.9 1.3 3.0 4.3 1.4 1.1 1.7 2.8
Hispanic/other 1.2 1.3 2.5 4.3 1.5 0.9 1.2 4.2
Family history of MI, % 32.1 32.8 32.4 29.8 32.5 31.2 32.0 29.8
Multivitamin use, % 44.0 43.2 44.6 44.2 42.5 49.2 51.1 53.0
Past or current PMH use, % 3.2 3.0 3.0 2.3 3.2 2.7 2.7 3.7
Current OC use, % 11.3 10.3 9.5 8.6 10.9 10.7 8.7 7.9
Hypertension, % 6.4 6.1 6.2 6.6 6.5 5.4 5.7 3.9
Hypercholesterolemia, % 14.6 14.2 14.9 16.9 14.8 13.7 13.6 15.3
Diabetes, % 1.0 1.0 0.9 1.0 1.0 0.8 0.9 1.2
Current aspirin use, % 11.5 11.1 10.6 8.8 11.2 11.0 10.8 11.6
Total energy intake, kcal/d 1692 6 531 1854 6 529 2010 6 546 2094 6 600 1758 6 543 1891 6 536 2013 6 548 2203 6 583
Glycemic load 120.3 6 22.4 120.6 6 19.8 125.0 6 19.9 136.4 6 24.6 120.5 6 21.6 122.9 6 20.2 129.1 6 21.1 140.9 6 24.0
White rice intake, servings/d — — — — 0.15 6 0.23 0.14 6 0.14 0.17 6 0.20 0.24 6 0.35
Brown rice intake, servings/d 0.06 6 0.12 0.06 6 0.10 0.07 6 0.14 0.08 6 0.22 ————
Whole-grain intake,
2 g/d 17.2 6 12.9 16.9 6 12.2 17.2 6 13.9 13.4 6 12.6 16.3 6 12.3 19.5 6 13.8 22.1 6 15.5 26.5 6 19.3
Modiﬁed aHEI score 45.1 6 10.4 46.1 6 9.8 47.6 6 9.8 49.3 6 9.8 44.7 6 9.9 49.7 6 9.9 53.2 6 10.0 56.4 6 10.5
HPFS
n 26,391 10,521 4400 858 34,257 5603 1970 340
Age, y 53.9 6 9.6 51.4 6 9.1 51.5 6 9.2 51.4 6 8.9 53.4 6 9.5 51.1 6 9.1 51.7 6 9.4 52.0 6 8.9
BMI, kg/m
2 25.0 6 5.0 25.0 6 4.9 24.8 6 5.1 24.3 6 4.5 25.0 6 4.9 24.8 6 4.9 24.5 6 5.2 24.0 6 4.2
Physical activity, MET-h/wk 20.9 6 29.1 21.9 6 29.5 21.8 6 31.2 21.0 6 28.9 20.1 6 28.5 25.2 6 32.0 27.7 6 32.9 34.1 6 39.7
Alcohol intake, g/d 11.4 6 15.7 11.6 6 15.3 11.5 6 14.9 8.5 6 13.4 11.4 6 15.6 11.6 6 15.5 11.0 6 14.1 8.2 6 11.5
Current smoker, % 10.3 8.7 8.6 7.7 10.3 7.4 6.5 7.4
(Continued)
RICE CONSUMPTION AND CVD 167and groundwater arsenic concentration were not found (see
Supplemental Table 4).
In sensitivity analyses (adjusting for individual dietary factors
instead of modiﬁed aHEI score, excluding participants who had
prevalent hypertension at baseline, and updating dietary in-
formationevery8yinsteadofevery4y),theassociationsofCVD
were largely similar to the results from primary analyses (see
Supplemental Table 5).
DISCUSSION
In these well-characterized large cohorts of U.S. male and
female health professionals, we did not ﬁnd signiﬁcant associ-
ations between rice consumption and risk of developing CVD or
CAD independently of demographic, lifestyle, and dietary risk
factors of CVD. These null associations were largely similar
between whites and Asians.
Rice consumption is known to contribute to arsenic exposure
among populations who live in arsenic-endemic regions in
Bangladesh, Taiwan, and India (5, 6). In the United States, rice
and rice products are also one of the major dietary sources of
exposuretototalandinorganicarsenic(24,32).Chronicexposure
to arsenic, especially inorganic arsenic, may be atherogenic
through multifaceted detrimental effects on blood pressure,
systemic inﬂammation, oxidative stress, and endothelial dys-
function (33). In arsenic-endemic regions, high arsenic con-
centration in drinking water was associated with increased risk of
CVD (34–37). However, ﬁndings from non–arsenic-endemic
areas were mixed. In 3 ecological studies, regional arsenic
concentration in groundwater was associated with an increased
CVD risk in Spain and the United States (38–40), although in
other 2 ecological studies in the United States, such a positive
association was not found (41, 42). In the only prospective
study, higher urinary concentration of inorganic plus methylated
organic arsenic species (arsenite, arsenate, monomethylarsenate,
and dimethylarsinate; median concentration of 9.7 mg/g creati-
nine with a range of 0.1–183.4 mg/g creatinine) was associated
with elevated risks of CVD, CAD, and stroke among U.S. adults
living in Arizona, Oklahoma, and the Dakotas, independently of
age, sex, educational levels, smoking status, BMI, and plasma
concentration of LDL cholesterol (43).
In contrast to the evidence regarding arsenic concentration in
drinking water, evidence on the association of rice consumption
as a route of arsenic exposure in relation to CVD risk is sparse.
The current analysis provides new evidence suggesting that in
U.S. populations with overalllow rice intake, rice consumption is
unlikely to contribute to an elevated risk of CVD or CAD. Our
ﬁndings are in line with the ﬁndings in a Japanese population
who, on average, consumed a much greater amount of white rice
than did our population (9, 10). Meanwhile, in the current
analysis, consumption of 5 or more servings/wk of white rice or
brown rice was nonsigniﬁcantly associated with a higher stroke
risk. However, such an association was largely abolished when
we examined the same amount of total rice intake in relation to
stroke risk. Also, in the exploratory analysis stratifying by the
groundwater arsenic concentrations in the participant’s county of
residence, we found a marginal interaction between rice con-
sumption and groundwater arsenic concentration in the partici-
pant’s county of residence in relation to CVD risk: white rice
consumption was positively associated with CVD risk only in
regions where groundwater arsenic concentration was low.
These nonsigniﬁcant ﬁndings, however, can be detected simply
by chance, and further investigations with individual-level data
of arsenic exposure from dietary and environmental routes are
warranted.
The possible reasons for the lack of positive associations
between rice consumption and CVD risk are worth discussing.
TABLE 1 (Continued)
White rice intake, servings/wk Brown rice intake, servings/wk
,1 1 2–4 $5 ,1 1 2–4 $5
Ethnicity, %
White 96.8 96.1 90.9 48.0 95.0 96.2 94.2 84.1
Asian 0.3 0.5 4.1 46.7 1.8 0.6 1.7 11.8
African American 2.2 2.4 2.5 3.3 2.3 2.3 2.4 2.9
Hispanic/other 0.7 1.0 2.6 2.0 1.0 0.9 1.7 1.2
Family history of MI, % 32.3 31.5 31.1 26.0 32.0 31.5 30.7 35.9
Multivitamin use 42.5 40.0 40.4 43.4 40.5 45.0 50.7 51.8
Hypertension, % 20.5 18.0 20.3 21.6 20.5 17.3 17.1 17.4
Hypercholesterolemia, % 10.2 10.4 11.8 11.9 10.2 11.2 12.8 15.0
Diabetes, % 2.5 2.3 2.5 3.4 2.6 2.1 2.2 2.4
Current aspirin use, % 27.0 26.6 25.9 19.0 26.8 25.9 25.2 21.2
Total energy intake, kcal/d 1911 6 597 2097 6 615 2243 6 647 2189 6 711 1963 6 613 2115 6 618 2214 6 646 2327 6 727
Glycemic load 122.0 6 26.5 125.0 6 23.5 129.9 6 24.1 142.8 6 28.1 122.4 6 25.6 127.8 6 24.8 135.3 6 26.2 153.1 6 29.4
White rice intake, servings/d — — — — 0.12 6 0.22 0.13 6 0.14 0.17 6 0.20 0.24 6 0.41
Brown rice intake, servings/d 0.06 6 0.14 0.07 6 0.11 0.09 6 0.16 0.08 6 0.24 ————
Whole-grain intake,
2 g/d 18.3 6 17.4 17.6 6 16.4 17.4 6 18.0 14.0 6 16.3 17.2 6 16.4 20.2 6 19.0 22.9 6 20.6 29.5 6 30.2
Modiﬁed aHEI score 49.7 6 11.0 50.6 6 10.5 51.2 6 10.5 50.4 6 10.2 49.1 6 10.7 53.3 6 10.2 56.2 6 10.3 59.4 6 9.6
1Values are means 6 SDs unless otherwise indicated. aHEI, alternate Healthy Eating Index; HPFS, Health Professionals Follow-Up Study; MET-h,
metabolic equivalent task-hours; MI, myocardial infarction; NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II; OC, oral contraceptive; PMH,
postmenopausal hormone.
2Whole-grain intake was assessed from other than brown rice.
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Prospective associations of rice consumption with cardiovascular disease among adults in the NHS, NHSII, and HPFS
1
Rice intake, servings/wk
Every 3 servings/wk P-trend ,1 1 2–4 $5
Cardiovascular disease
White rice
No. at risk 125,905 56,473 21,648 3530
Cases/person-years 6175/1,979,490 3735/1,434,839 2261/878,523 220/100,278
Model 1
2 1.00 0.97 (0.93, 1.01) 0.96 (0.91, 1.01) 0.84 (0.73, 0.96) 0.94 (0.89, 0.98) 0.01
Model 2
3 1.00 1.01 (0.97, 1.05) 1.00 (0.95, 1.05) 0.95 (0.82, 1.11) 0.99 (0.94, 1.05) 0.78
Model 3
4 1.00 1.01 (0.97, 1.05) 1.02 (0.97, 1.07) 0.98 (0.84, 1.14) 1.01 (0.96, 1.06) 0.69
Brown rice
No. at risk 176,888 21,866 7610 1192
Cases/person-years 10,159/3,483,943 1436/582,370 727/296,734 69/30,083
Model 1
2 1.00 0.89 (0.84, 0.94) 0.85 (0.79, 0.92) 0.77 (0.61, 0.98) 0.82 (0.76, 0.88) ,0.001
Model 2
3 1.00 0.96 (0.91, 1.02) 0.96 (0.89, 1.04) 0.86 (0.68, 1.10) 0.94 (0.87, 1.01) 0.10
Model 3
4 1.00 1.01 (0.95, 1.07) 1.05 (0.97, 1.13) 1.01 (0.79, 1.28) 1.04 (0.96, 1.13) 0.32
Total rice
No. at risk 88,619 61,433 41,849 15,655
Cases/person-years 4104/1,222,338 3924/1,401,634 3738/1,467,592 625/301,565
Model 1
2 1.00 0.91 (0.87, 0.95) 0.87 (0.83, 0.91) 0.80 (0.73, 0.87) 0.88 (0.84, 0.91) ,0.001
Model 2
3 1.00 0.98 (0.94, 1.02) 0.97 (0.92, 1.01) 0.92 (0.84, 1.00) 0.96 (0.92, 1.00) 0.06
Model 3
4 1.00 1.00 (0.95, 1.04) 1.01 (0.96, 1.06) 0.99 (0.90, 1.08) 1.00 (0.96, 1.05) 0.86
Coronary artery disease
White rice
No. at risk 125,905 56,473 21,648 3530
Cases/person-years 3848/1,979,490 2328/1,434,839 1417/878,523 126/100,278
Model 1
2 1.00 0.99 (0.94, 1.04) 0.98 (0.92, 1.04) 0.74 (0.62, 0.89) 0.93 (0.87, 0.98) 0.01
Model 2
3 1.00 1.03 (0.98, 1.09) 1.03 (0.96, 1.09) 0.81 (0.66, 0.99) 0.98 (0.92, 1.05) 0.61
Model 3
4 1.00 1.04 (0.98, 1.09) 1.05 (0.98, 1.12) 0.84 (0.69, 1.02) 1.01 (0.94, 1.07) 0.87
Brown rice
No. at risk 176,888 21,866 7610 1192
Cases/person-years 6328/3,483,943 899/582,370 457/296,734 35/30,083
Model 1
2 1.00 0.86 (0.80, 0.92) 0.83 (0.75, 0.91) 0.59 (0.42, 0.82) 0.76 (0.69, 0.84) ,0.001
Model 2
3 1.00 0.94 (0.87, 1.01) 0.95 (0.86, 1.04) 0.66 (0.47, 0.92) 0.88 (0.80, 0.97) 0.01
Model 3
4 1.00 0.99 (0.92, 1.06) 1.05 (0.95, 1.16) 0.80 (0.57, 1.12) 1.00 (0.91, 1.11) 0.95
Total rice
No. at risk 88,619 61,433 41,849 15,655
Cases/person-years 2547/1,222,338 2467/1,401,634 2309/1,467,592 396/301,565
Model 1
2 1.00 0.93 (0.88, 0.99) 0.86 (0.81, 0.91) 0.76 (0.69, 0.85) 0.86 (0.81, 0.90) ,0.001
Model 2
3 1.00 1.01 (0.96, 1.07) 0.98 (0.92, 1.04) 0.88 (0.78, 0.98) 0.94 (0.90, 0.99) 0.03
Model 3
4 1.00 1.03 (0.98, 1.09) 1.03 (0.97, 1.09) 0.97 (0.86, 1.08) 0.99 (0.94, 1.05) 0.81
Stroke
White rice
No. at risk 125,905 56,473 21,648 3530
Cases/person-years 2327/1,979,490 1407/1,434,839 844/878,523 94/100,278
Model 1
2 1.00 0.94 (0.88, 1.01) 0.93 (0.86, 1.01) 1.02 (0.83, 1.26) 0.96 (0.89, 1.04) 0.31
Model 2
3 1.00 0.97 (0.90, 1.03) 0.96 (0.89, 1.04) 1.23 (0.97, 1.55) 1.01 (0.93, 1.10) 0.85
Model 3
4 1.00 0.97 (0.90, 1.03) 0.97 (0.89, 1.05) 1.25 (0.99, 1.57) 1.02 (0.94, 1.11) 0.67
Brown rice
No. at risk 176,888 21,866 7610 1192
Cases/person-years 3831/3,483,943 537/582,370 270/296,734 34/30,083
Model 1
2 1.00 0.94 (0.86, 1.03) 0.89 (0.79, 1.01) 1.14 (0.81, 1.59) 0.92 (0.82, 1.04) 0.20
Model 2
3 1.00 1.00 (0.91, 1.10) 0.99 (0.87, 1.12) 1.28 (0.91, 1.80) 1.04 (0.92, 1.17) 0.58
Model 3
4 1.00 1.03 (0.94, 1.14) 1.05 (0.92, 1.19) 1.39 (0.99, 1.96) 1.11 (0.98, 1.26) 0.12
Total rice
No. at risk 88,619 61,433 41,849 15,655
Cases/person-years 1557/1,222,338 1457/1,401,634 1429/1,467,592 229/301,565
Model 1
2 1.00 0.88 (0.82, 0.94) 0.88 (0.81, 0.94) 0.86 (0.75, 0.99) 0.92 (0.86, 0.98) 0.01
Model 2
3 1.00 0.93 (0.86, 1.00) 0.95 (0.88, 1.03) 0.99 (0.86, 1.15) 0.99 (0.93, 1.06) 0.83
Model 3
4 1.00 0.94 (0.87, 1.01) 0.98 (0.91, 1.06) 1.04 (0.89, 1.21) 1.02 (0.95, 1.10) 0.55
1HPFS, Health Professionals Follow-Up Study; NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II.
2HRs(95%CIs)inmodel1wereestimatedbyCoxproportionalhazardsregressionstratifyingjointlybyage(y),sex(maleorfemale),andcohorts(NHS,NHSII,orHPFS).
3HRs (95% CIs) in model 2 were estimated by Cox proportional hazards regression further adjusting for ethnicity (white, Asian, African American, and Hispanic/
other), BMI (in kg/m
2; ,23.0, 23.0–24.9, 25.0–29.9, 30.0–34.9, or $35.0), smoking status [never smoked, past smoker, or currently smoke (1–14 or $15 cigarettes/
d)], alcohol intake (0, 0.1–4.9, 5.0–9.9, 10.0–14.9, 15.0–29.9, or $30.0 g/d), physical activity (,3.0, 3.0–8.9, 9.0–17.9, 18.0–26.9, or $27.0 metabolic equivalent tasks
3 hours/wk), family history of myocardial infarction (yes or no), menopausal status and postmenopausal hormone use [premenopause, postmenopause (never, past, or
current hormone use), for women], oral contraceptive use (never, past, or current use, for NHSII only), multivitamin use (yes or no), current aspirin use (yes or no),
prevalent hypertension (yes or no), prevalent hypercholesterolemia (yes or no), prevalent diabetes (yes or no), and total energy intake (kcal/d).
4HRs (95% CIs) in model 3 were estimated by Cox proportional hazards regression further adjusting for modiﬁed alternate Healthy Eating Index score
(quintiles) as a summary measure of diet quality.
RICE CONSUMPTION AND CVD 169First, in a study conducted among U.S. pregnant women, rice
consumption explained only 4% of the variability of urinary total
arsenic concentration, whereas arsenic intake from drinking
water explained 12% (2). Because of the relatively low contri-
bution of rice consumption to arsenic exposure, potential health
effects of arsenic exposure from rice consumption may be easily
masked by those of arsenic exposure from other routes such as
drinking water. Second, arsenic concentrations in rice grains may
vary substantially across rice cultivars, cultivating methods
(ﬂooding or nonﬂooding), irrigation water usage, and arsenic
contents in soil and irrigation water (44–46). Moreover, cooking
methods and arsenic contents in cooking water may modify
arsenic contents in cooked rice (46). Furthermore, the bio-
availability of arsenic in rice also varies across rice cultivars and
cooking methods (47, 48). The variation of bioavailable arsenic
concentrations in cooked rice may dilute the importance of ar-
senic exposure from rice consumption. Last, whole rice grains
(brown rice) contain insoluble ﬁber, magnesium, vitamin E (49),
and phytochemicals (50, 51) that may jointly have beneﬁcial
effects on cardiovascular health (52–55) through lowering blood
pressure levels (56–58) and blood cholesterol concentration (50,
58–60), improving glucose metabolism (61), and reducing oxi-
dative stress (62). These beneﬁcial effects of whole-grain rice
may counteract the adverse effects exerted by arsenic exposure
from rice consumption. In contrast, reﬁned rice grains (white
rice) contain less arsenic and the abovementioned nutrients be-
cause rice bran rich in these substances is removed during
polishing (63). The polishing process may also make rice grains
easily absorbable and leads to an increased glycemic index and
glycemic load, which is a dietary risk factor of CVD (64).
However, in our populations, white rice was only a minor con-
tributor to the overall dietary glycemic index or load.
Strengths of the current study include a prospective study
design, large sample size, and repeated measurements of expo-
sure and various confounders. The current study also has several
limitations.First,riceconsumptionintheUnitedStateswasmuch
lower than that in Asian countries, and we therefore are unable to
extrapolate whether at much higher intakes, rice intake is as-
sociated with CVD risk from the current ﬁndings. Second, our
study participants primarily consisted of health professionals
with European ancestry, further limiting the generalizability of
our ﬁndings to populations of different ethnicities. Third, mea-
surement error in assessments of rice consumption is inevitable,
and we have incomplete knowledge of the extent to which such
error may bias our results. To minimize random errors, we
calculated and used the cumulative average of rice consumption
during follow-up. Because of the prospective study design,
measurement errors of rice consumption are more likely to be
random and thus bias the associations toward the null. Fourth,
we had no individual data on water usage from public water
supplies, private wells, bottled water, and other sources. The
county-level groundwater arsenic concentration may not nec-
essarily reﬂect the actual arsenic exposure from drinking water.
Because the measurement error is unlikely to be related with
disease outcomes, such nondifferential errors will be more
likely to dilute true associations to the null. Last, we cannot
eliminate the possibility that our ﬁndings were due to chance or
residual confounding. For example, serum concentrations of
LDL cholesterol were not available in all 3 cohorts. Although
we adjusted for a self-reported hypercholesterolemia, which
was reliable to use as a covariate (65), some residual con-
founding may still exist (66).
In conclusion, greater consumption of white rice or brown rice
was not associated with an increased risk of CVD or CAD in U.S.
men and women. Although a recent report from Consumer
Reports magazine recommended limiting rice consumption to
2 servings/wk or less (7), the current evidence does not lend
support to such a recommendation. Further evidence is never-
theless needed to elucidate the interrelationships among arsenic
exposures from multiple sources, intake of various types of rice
grains, and CVD risk, as well as other disease outcomes.
The original data sets of the NHS, NHS II, and HPFS were accessible in
accordance with the guideline for external collaborators available at the web-
site of the NHS (http://www.channing.harvard.edu/nhs/?page_id=471) and
the HPFS (http://www.hsph.harvard.edu/hpfs/hpfs_collaborators.htm).
The authors’ responsibilities were as follows—IM, WCW, and QS: study
concept and design; FL, EBR, and WCW: acquisition of data; IM, HW, FI,
FL, EBR, FBH, WCW, and QS: analysis and interpretation of data and
critical revision of the manuscript for important intellectual content; IM:
drafting of the manuscript and statistical analysis; EBR, FBH, and WCW:
funding acquisition; FL, EBR, FBH, and WCW: administrative, technical, or
material support; and WCW and QS: study supervision. The funding orga-
nizations had no role in the design and conduct of the study; in the collec-
tion, analysis, and interpretation of the data; or in the preparation, review, or
approval of the manuscript. All authors reported no conﬂicts of interest
related to the study.
REFERENCES
1. U.S. Department of Agriculture, Economic Research Service. Food
Availability (Per Capita) Data System [Internet]. Washington, DC: U.S.
Department of Agriculture [cited 2013 Nov 25]. Available from: http://
www.ers.usda.gov/data-products/food-availability-(per-capita)-data-
system/aspx.
2. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath
V, Gandolﬁ AJ, Baker ER, Jackson BP, Folt CL, Karagas MR. Rice
consumption contributes to arsenic exposure in US women. Proc Natl
Acad Sci USA 2011;108:20656–60.
3. Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D,
Punshon T, Karagas MR. Rice consumption and urinary arsenic con-
centrations in U.S. children. Environ Health Perspect 2012;120:
1418–24.
4. Oguri T, Yoshinaga J, Tao H, Nakazato T. Inorganic arsenic in the
Japanese diet: daily intake and source. Arch Environ Contam Toxicol
2014;66:100–12.
5. Ohno K, Yanase T, Matsuo Y, Kimura T, Rahman MH, Magara Y,
Matsui Y. Arsenic intake via water and food by a population living in
an arsenic-affected area of Bangladesh. Sci Total Environ 2007;381:
68–76.
6. Signes-Pastor AJ, Mitra K, Sarkhel S, Hobbes M, Burlo ´ F, de Groot
WT, Carbonell-Barrachina AA. Arsenic speciation in food and esti-
mation of the dietary intake of inorganic arsenic in a rural village of
West Bengal, India. J Agric Food Chem 2008;56:9469–74.
7. Reports C. Arsenic in your food: our ﬁndings show a real need for
federal standards for this toxin. Consum Rep 2012;77:22–7.
8. U.S. Food and Drug Administration. Arsenic in Rice and Rice Products
[Internet]. Silver Spring (MD): U.S. Food and Drug Administration
[cited 2013 Nov 25]. Available from: http://www.fda.gov/Food/Food-
borneIllnessContaminants/Metals/ucm319870.htm.
9. Eshak ES, Iso H, Date C, Yamagishi K, Kikuchi S, Watanabe Y,
Wada Y, Tamakoshi A; JACC Study Group. Rice intake is associated
with reduced risk of mortality from cardiovascular disease in Japanese
men but not women. J Nutr 2011;141:595–602.
10. Eshak ES, Iso H, Yamagishi K, Kokubo Y, Saito I, Yatsuya H, Sawada N,
Inoue M, Tsugane S. Rice consumption is not associated with risk of
cardiovascular disease morbidity or mortality in Japanese men and
women: a large population-based, prospective cohort study. Am J Clin
Nutr 2014;141:199–207.
170 MURAKI ET AL.11. Sawada N, Iwasaki M, Inoue M, Takachi R, Sasazuki S, Yamaji T,
Shimazu T, Tsugane S. Dietary arsenic intake and subsequent risk of
cancer: the Japan Public Health Center–based (JPHC) Prospective
Study. Cancer Causes Control 2013;24:1403–15.
12. Yu D, Shu XO, Li H, Xiang YB, Yang G, Gao YT, Zheng W, Zhang X.
Dietary carbohydrates, reﬁned grains, glycemic load, and risk of cor-
onary heart disease in Chinese adults. Am J Epidemiol 2013;178:1542–9.
13. Varraso R, Kabrhel C, Goldhaber SZ, Rimm EB, Camargo CA Jr.
Prospective study of diet and venous thromboembolism in US women
and men. Am J Epidemiol 2012;175:114–26.
14. Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB.
High anthocyanin intake is associated with a reduced risk of myocar-
dial infarction in young and middle-aged women. Circulation 2013;
127:188–96.
15. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B,
Hennekens CH, Speizer FE. The use of a self-administered questionnaire
to assess diet four years in the past. Am J Epidemiol 1988;127:188–99.
16. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB,
Willett WC. Reproducibility and validity of an expanded self-
administered semiquantitative food frequency questionnaire among
male health professionals. Am J Epidemiol 1992;135:1114–26.
17. Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M,
Stampfer MJ, Willett WC. Alternative dietary indices both strongly
predict risk of chronic disease. J Nutr 2012;142:1009–18.
18. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B,
Willett WC. Food-based validation of a dietary questionnaire: the ef-
fects of week-to-week variation in food consumption. Int J Epidemiol
1989;18:858–67.
19. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ,
Litin LB, Willett WC. Reproducibility and validity of food intake
measurements from a semiquantitative food frequency questionnaire.
J Am Diet Assoc 1993;93:790–6.
20. Thompson FE, Kipnis V, Midthune D, Freedman LS, Carroll RJ, Subar
AF, Brown CC, Butcher MS, Mouw T, Leitzmann M, et al. Perfor-
mance of a food-frequency questionnaire in the US NIH-AARP (Na-
tional Institutes of Health-American Association of Retired Persons)
Diet and Health Study. Public Health Nutr 2008;11:183–95.
21. Kaaks R, Slimani N, Riboli E. Pilot phase studies on the accuracy of
dietary intake measurements in the EPIC project: overall evaluation of
results. European Prospective Investigation into Cancer and Nutrition.
Int J Epidemiol 1997;26(Suppl 1):S26–36.
22. Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W, Gao YT, Zheng W.
Validity and reproducibility of the food frequency questionnaire used
in the Shanghai Women’s Health Study. Eur J Clin Nutr 2004;58:
17–23.
23. Villegas R, Yang G, Liu D, Xiang YB, Cai H, Zheng W, Shu XO.
Validity and reproducibility of the food-frequency questionnaire used
in the Shanghai Men’s Health Study. Br J Nutr 2007;97:993–1000.
24. MacIntosh DL, Williams PL, Hunter DJ, Sampson LA, Morris SC,
Willett WC, Rimm EB. Evaluation of a food frequency questionnaire–
food composition approach for estimating dietary intake of inorganic
arsenic and methylmercury. Cancer Epidemiol Biomarkers Prev 1997;6:
1043–50.
25. U.S. Geological Survey. Trace Elements National Synthesis Project
[Internet]. Chula Vista (CA): U.S. Geological Survey [cited 2013 Nov
25]. Available from: http://water.usgs.gov/nawqa/trace/arsenic/.
26. U.S. Environmental Protection Agency. National Primary Drinking
Water Regulations; Arsenic and Clariﬁcations to Compliance and New
Source Contaminants Monitoring [Internet]. Washington, DC: U.S.
Environmental Protection Agency 1999 [cited 2013 Nov 25]. Available
from: http://www.epa.gov/rfa/drinking-water-arsenic.html.
27. Rose G, Blackburn H. Cardiovascular survey methods. World Health
Organization monograph series no. 56, 2nd ed. Geneva (Switzerland):
World Health Organization; 1982.
28. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke:
clinical ﬁndings. Stroke 1981;12(2 Pt 2, Suppl 1):I13–44.
29. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National
Death Index and Equifax Nationwide Death Search. Am J Epidemiol
1994;140:1016–9.
30. Hu FB, Stampfer MJ, Rimm EB, Ascherio A, Rosner BA, Spiegelman
D, Willett WC. Dietary fat and coronary heart disease: a comparison of
approaches for adjusting for total energy intake and modeling repeated
dietary measurements. Am J Epidemiol 1999;149:531–40.
31. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:
187–220.
32. Xue J, Zartarian V, Wang SW, Liu SV, Georgopoulos P. Probabilistic
modeling of dietary arsenic exposure and dose and evaluation with
2003-2004 NHANES data. Environ Health Perspect 2010;118:345–50.
33. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D,
Rhodes CJ, Valko M. Arsenic: toxicity, oxidative stress and human
disease. J Appl Toxicol 2011;31:95–107.
34. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardio-
vascular disease: an updated systematic review. Curr Atheroscler Rep
2012;14:542–55.
35. Liao YT, Chen CJ, Li WF, Hsu LI, Tsai LY, Huang YL, Sun CW, Chen
WJ, Wang SL. Elevated lactate dehydrogenase activity and increased
cardiovascular mortality in the arsenic-endemic areas of southwestern
Taiwan. Toxicol Appl Pharmacol 2012;262:232–7.
36. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, Argos
M, Islam T, Ahmed A, Rakibuz-Zaman M, et al. Arsenic exposure from
drinking water and mortality from cardiovascular disease in Bangla-
desh: prospective cohort study. BMJ 2011;342:d2431.
37. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J,
Bates MN, Smith AH. Acute myocardial infarction mortality in
comparison with lung and bladder cancer mortality in arsenic-
exposed region II of Chile from 1950 to 2000. Am J Epidemiol 2007;
166:1381–91.
38. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. Arsenic in drinking
water and cerebrovascular disease, diabetes mellitus, and kidney dis-
ease in Michigan: a standardized mortality ratio analysis. Environ
Health 2007;6:4.
39. Medrano MA, Boix R, Pastor-Barriuso R, Palau M, Damia ´n J, Ramis
R, Del Barrio JL, Navas-Acien A. Arsenic in public water supplies and
cardiovascular mortality in Spain. Environ Res 2010;110:448–54.
40. Lisabeth LD, Ahn HJ, Chen JJ, Sealy-Jefferson S, Burke JF, Meliker
JR. Arsenic in drinking water and stroke hospitalizations in Michigan.
Stroke 2010;41:2499–504.
41. Engel RR, Smith AH. Arsenic in drinking water and mortality from
vascular disease: an ecologic analysis in 30 counties in the United
States. Arch Environ Health 1994;49:418–27.
42. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL.
Drinking water arsenic in Utah: a cohort mortality study. Environ
Health Perspect 1999;107:359–65.
43. Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi
KA, Goessler W, Pollak J, Silbergeld EK, Howard BV, et al. Associ-
ation between exposure to low to moderate arsenic levels and incident
cardiovascular disease: a prospective cohort study. Ann Intern Med
2013;159:649–59.
44. Norton GJ, Pinson SR, Alexander J, McKay S, Hansen H, Duan GL,
Raﬁqul Islam M, Islam S, Stroud JL, Zhao FJ, et al. Variation in grain
arsenic assessed in a diverse panel of rice (Oryza sativa) grown in
multiple sites. New Phytol 2012;193:650–64.
45. Sidhu SS, Brar JS, Biswas A, Banger K, Saroa GS. Arsenic contami-
nation in soil-water-plant (rice, Oryza sativa L.) continuum in central
and sub-mountainous Punjab, India. Bull Environ Contam Toxicol
2012;89:1046–50.
46. Rahman MA, Hasegawa H. High levels of inorganic arsenic in rice in
areas where arsenic-contaminated water is used for irrigation and
cooking. Sci Total Environ 2011;409:4645–55.
47. Trenary HR, Creed PA, Young AR, Mantha M, Schwegel CA, Xue J,
Kohan MJ, Herbin-Davis K, Thomas DJ, Caruso JA, et al. An in vitro
assessment of bioaccessibility of arsenicals in rice and the use of this
estimate within a probabilistic exposure model. J Expo Sci Environ
Epidemiol 2012;22:369–75.
48. He Y, Pedigo CE, Lam B, Cheng Z, Zheng Y. Bioaccessibility of ar-
senic in various types of rice in an in vitro gastrointestinal ﬂuid system.
J Environ Sci Health B 2012;47:74–80.
49. U.S. Department of Agriculture, Agricultural Research Service. 2013
USDA National Nutrient Database for Standard Reference, Release 26.
Nutrient Data Laboratory Home Page [Internet]. Washington, DC: U.S.
Department of Agriculture; 2013 [cited 2013 Nov 26]. Available from:
http://www.ars.usda.gov/ba/bhnrc/ndl.
50. Tham DM, Gardner CD, Haskell WL. Clinical review 97: potential
health beneﬁts of dietary phytoestrogens: a review of the clinical, ep-
idemiological, and mechanistic evidence. J Clin Endocrinol Metab
1998;83:2223–35.
RICE CONSUMPTION AND CVD 17151. Manach C, Scalbert A, Morand C, Re ´me ´sy C, Jime ´nez L. Polyphenols:
food sources and bioavailability. Am J Clin Nutr 2004;79:727–47.
52. Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U,
Heitmann BL, Hallmans G, Knekt P, Liu S, Pietinen P, et al. Dietary
ﬁber and risk of coronary heart disease: a pooled analysis of cohort
studies. Arch Intern Med 2004;164:370–6.
53. Champagne CM. Magnesium in hypertension, cardiovascular disease,
metabolic syndrome, and other conditions: a review. Nutr Clin Pract
2008;23:142–51.
54. Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary
heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev
Rehabil 2008;15:26–34.
55. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain
intake is associated with lower risk of type 2 diabetes, cardiovascular
disease, and weight gain. J Nutr 2012;142:1304–13.
56. Streppel MT, Arends LR, van ’t Veer P, Grobbee DE, Geleijnse JM.
Dietary ﬁber and blood pressure: a meta-analysis of randomized
placebo-controlled trials. Arch Intern Med 2005;165:150–6.
57. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation
on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411–8.
58. Ardiansyah, Koseki T, Hashizume K, Komai M. The Driselase-treated
fraction of rice bran is a more effective dietary factor to improve hy-
pertension, glucose and lipid metabolism in stroke-prone spontaneously
hypertensive rats compared to ferulic acid. Br J Nutr 2007;97:67–76.
59. Brown L, Rosner B, Willett WC, Sacks FM. Cholesterol-lowering ef-
fects of dietary ﬁber: a meta-analysis. Am J Clin Nutr 1999;69:30–42.
60. Eady S, Wallace A, Willis J, Scott R, Frampton C. Consumption of
a plant sterol-based spread derived from rice bran oil is effective at
reducing plasma lipid levels in mildly hypercholesterolaemic in-
dividuals. Br J Nutr 2011;105:1808–18.
61. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral mag-
nesium supplementation on glycaemic control in type 2 diabetes:
a meta-analysis of randomized double-blind controlled trials. Diabet
Med 2006;23:1050–6.
62. Traber MG, Stevens JF. Vitamins C and E: beneﬁcial effects
from a mechanistic perspective. Free Radic Biol Med 2011;51:
1000–13.
63. Rahman MA, Hasegawa H, Rahman MM, Rahman MA, Miah MA.
Accumulation of arsenic in tissues of rice plant (Oryza sativa L.) and
its distribution in fractions of rice grain. Chemosphere 2007;69:
942–8.
64. Fan J, Song Y, Wang Y, Hui R, Zhang W. Dietary glycemic index,
glycemic load, and risk of coronary heart disease, stroke, and stroke
mortality: a systematic review with meta-analysis. PLoS One 2012;7:
e52182.
65. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L,
Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire
information on risk factors and disease outcomes in a prospective
cohort study of women. Am J Epidemiol 1986;123:894–900.
66. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ,
de Graaf J, Furberg CD. A meta-analysis of low-density lipoprotein
cholesterol, non-high-density lipoprotein cholesterol, and apolipopro-
tein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes
2011;4:337–45.
172 MURAKI ET AL.